https://ki.se RSS News Listing https://news.ki.se/ki-and-st-erik-eye-hospital-expand-collaboration-on-advanced-therapies The Karolinska ATMP Center — a collaboration between Karolinska Institutet (KI) and Karolinska University Hospital — and St. Erik Eye Hospital have signed a letter of intent to strengthen their partnership in research, development, and clinical trials of cell- and gene-based medicines, known as Advanced Therapy Medicinal Products (ATMPs). The goal is to accelerate the transition from research to clinical application, particularly for retinal diseases that currently lack effective treatments. Thu, 04 Sep 2025 15:12:36 +0200 https://news.ki.se/preparations-for-the-first-car-t-treatment-for-multiple-myeloma-in-routine-healthcare Karolinska University Hospital has, for the first time in Sweden, begun preparations to treat a patient with multiple myeloma using CAR-T cell therapy in routine healthcare – an advanced form of immunotherapy where the patient's own T-cells are programmed to attack cancer cells. The treatment is aimed at patients who no longer respond to previous treatment options and offers new hope for a difficult-to-treat blood cancer. Mon, 23 Jun 2025 15:03:01 +0200 https://news.ki.se/promising-results-after-car-t-cell-therapy-for-leukemia-and-lymphoma Swedish cancer patients treated with CAR T-cell therapy show better survival rates and fewer side effects than seen in previous studies. This is shown in a new compilation of Swedish treatment results conducted by researchers in the SWECARNET network. Mon, 12 May 2025 16:11:06 +0200 https://news.ki.se/new-doctoral-course-on-advanced-therapy-medicinal-products-atmps-at-ki-from-discovery-to-delivery Karolinska Institutet is launching a two-week doctoral course designed to provide a comprehensive overview of the entire process involved in developing and producing cell and gene therapy products. From early-stage research to manufacturing, the program covers key aspects including process development, quality assurance, regulatory frameworks, and logistics. Mon, 05 May 2025 09:38:15 +0200 https://news.ki.se/new-technology-facilitates-delivery-of-advanced-medicines Researchers at Karolinska Institutet have developed a technique that enables efficient delivery of therapeutic proteins and RNA to cells. The method, presented in Nature Communications, shows promising results in animal studies to deliver gene editors and protein therapeutics. Wed, 30 Apr 2025 13:11:52 +0200 https://news.ki.se/ki-researcher-takes-on-leading-role-in-european-cell-and-gene-therapy-organization Lindsay Davies, an researcher at Karolinska Institutet, has been elected Incoming Vice Chair for Europe within the International Society for Cell & Gene Therapy (ISCT), a global organization that brings together scientists, clinicians, regulators, and industry partners in the rapidly growing field of advanced therapies. Mon, 14 Apr 2025 13:48:01 +0200 https://news.ki.se/immunotherapy-for-liver-cancer-can-be-improved-with-new-insights-into-immune-cells T-cells from the liver and lymph nodes show promising potential for future treatments of liver cancer, according to a new study. Researchers at Karolinska Institutet have investigated how immune cells react to tumor-specific antigens in the complex environment surrounding liver cancer. Thu, 30 Jan 2025 09:30:27 +0100 https://news.ki.se/car-t-cell-therapy-is-here-to-stay Ten years ago, a cancer patient in Sweden was treated with CAR T-cell therapy for the first time. Today he is cured. Several challenges remain before the treatment can be given to everyone who could benefit from it, and how to achieve this was one of the questions discussed at the SWECARNET network’s annual education day. Tue, 17 Dec 2024 12:31:08 +0100 https://news.ki.se/nextgennk-and-ccrm-nordic-mini-symposium Advanced Medicinal Therapy Products, ATMP, span broadly over medical fields and the aim of this symposium is to enhance networking within ATMP and to get a flavor of academic and commercial development of ATMPs in Stockholm and Sweden. NextGenNK and CCRM Nordic are inviting you to a mini-symposium with the focus on ATMP on January 22, 2025. Tue, 10 Dec 2024 13:09:03 +0100 https://news.ki.se/knut-steffensen-becomes-new-director-of-karolinska-atmp-center On 4 November, Knut Steffensen will be taking up office as the director of the Karolinska ATMP Centre, a leading centre for advanced therapy medicinal products, with research, manufacture and treatment all under one roof. Sat, 19 Oct 2024 20:52:43 +0200 https://news.ki.se/gene-therapy-effective-in-hereditary-blindness Bothnia dystrophy is a form of hereditary blindness, prevalent in the region Västerbotten in Sweden. A new study at Karolinska Institutet published in Nature Communications shows that gene therapy can improve vision in patients with the disease. Tue, 10 Sep 2024 13:56:26 +0200 https://news.ki.se/bodys-message-in-a-bottle-delivers-targeted-cancer-treatment Researchers at Karolinska Institutet have succeeded in delivering targeted cancer treatment via small membrane bubbles that our cells use to communicate. A new study published in Nature Biomedical Engineering shows that the treatment reduces tumour growth and improves survival in mice. Mon, 20 May 2024 11:00:10 +0200 https://news.ki.se/sweden-signs-new-cooperation-agreement-with-the-us-on-cancer-research Sweden and the USA have previously enjoyed strong collaboration in the field of cancer care and research, and now it is further strengthened through a bilateral agreement. The purpose is to promote exchange between the two countries in both cancer research and the implementation of this research within cancer care, including both prevention and improved quality of life. Tue, 19 Mar 2024 16:38:56 +0100 https://news.ki.se/new-center-to-strengthen-investment-in-cell-gene-and-tissue-therapies Karolinska University Hospital's Director Björn Zoëga and Karolinska Institutet's President Annika Östman Wernerson have signed an agreement to establish a joint center for advanced cell, gene and tissue therapies. Wed, 12 Jul 2023 17:35:06 +0200